4.59 OPEN LABEL CLINICAL TRIAL OF SULFORAPHANE IN SCHOOL-AGED CHILDREN WITH AUTISM

Children with ASD have been found to have elevated markers of oxidative stress and impaired antioxidant function compared to children without autism. A previous study has shown a significant improvement in ASD symptoms after supplementing children with autism with sulforaphane; known to cause transcriptional up regulation of genes that control oxidative stress. This study reports changes in behavior of children with autism following sulforaphane supplementation.